NANO-X IMAGING LTD

NANO-X IMAGING LTD

NNASDAQ:NNOX
0.32
USD
+0.00
(-0.56%)
-1.72EPS
81.27MMarket Cap
Nov 19Next Earn
NANO-X IMAGING LTD
NASDAQ:NNOX
(Nasdaq Stock Market)

Recent

price

0.32

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
- -
- -
- -
0.03
0.16
0.18
0.19
0.2
0.23
Revenue per Share
-0.06
-0.66
-1.23
-1.28
-2.17
-1.08
-0.91
-1.16
-1.72
Basic EPS, GAAP
-0.11
-0.17
-1
-1.27
-0.97
-0.85
-0.67
-0.69
-0.77
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.14
-0.2
5.01
5.64
3.93
3.38
2.97
2.01
1.03
Book Value per Share
-0.14
-0.2
5.01
2.55
2.14
1.99
1.87
1.14
0.83
Tangible Book Value per Share
34
34
36
48
52
56
59
65
68
Basic Weighted Avg Shares
- -
- -
- -
1
9
10
11
13
16
Sales/Revenue/Turnover
- -
- -
- -
-4,720.71
-1,016.65
-602.29
-502.93
-466.16
-653.27
Operating Margin (%)
- -
- -
- -
2
12
12
12
12
11
Depreciation Expense
-2
-23
-44
-62
-113
-61
-54
-75
-117
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
-4,739.11
-1,320.16
-613.59
-474.31
-576.13
-747.2
Profit Margin (%)
-7
-11
215
42
57
73
65
50
25
Working Capital
- -
- -
1
5
4
4
4
4
4
LT Debt
-6
-9
231
292
217
196
189
140
72
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-23.64
-44.51
-29.49
-27.83
-45.62
-98.98
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4
4
4
LT Borrowings
- -
- -
- -
LT Finance Leases
4
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
70
70
70
Market Capitalization
195
158
81

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
67
51
39
Cash, Cash Equivalents & STI
60
44
31
Accounts Receivable, Net
2
2
2
Inventories
3
3
3
Total Current Liabilities
17
14
14
Payables & Accruals
7
6
5
ST Debt
4
4
4
Deferred Revenue
1
- -
1

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-7.67%
-26.11%
Free Cash Flow
- -
9.22%
14.31%
Net Income, GAAP
- -
21.24%
40.18%
Sales/Revenue/Turnover
- -
- -
15.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3
3
3
3
11
2025
3
3
3
4
13
2026
4
4
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.21
-0.23
-0.23
-0.23
-0.91
2025
-0.21
-0.23
-0.21
-0.5
-1.16
2026
-0.2
-0.79
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Nano-X Imaging Ltd. (NASDAQ: NNOX) develops and commercializes innovative medical imaging systems leveraging proprietary digital X-ray source technology to enable cost-effective, high-resolution tomographic imaging. The company offers the Nanox.ARC, an FDA-cleared, CE-marked digital multi-source 3D tomosynthesis imaging system for advanced radiographic visualization; the Nanox.ARC X, its next-generation FDA-cleared digital multi-source 3D tomosynthesis system with enhanced image detail and platform capabilities; Nanox.AI solutions, including FDA-cleared AI algorithms for cardiac, bone, and liver applications to detect asymptomatic chronic diseases; Nanox.SOURCE, a silicon-based nano-scale cold cathode X-ray source; and the Nanox.MARKETPLACE platform connecting imaging providers for global teleradiology services. Headquartered in Israel and founded in 2011, Nano-X Imaging operates primarily in the medical imaging sector, targeting healthcare providers, hospitals, and diagnostic facilities worldwide with a focus on improving global health equity through accessible advanced diagnostics. In recent developments, the company announced an agreement on November 19, 2025, to acquire VasoHealthcare IT from Vaso Corporation for up to $800,000 to bolster U.S. AI expansion; extended its collaboration with USARAD Holdings for advanced radiology diagnostics; partnered with Czech distributor EXRAY to penetrate over 50% of the Czech imaging market with Nanox.ARC sales and service; and completed a $15 million registered direct offering of ordinary shares to support growth initiatives, alongside reporting Q2 2025 revenue of $3.0 million.

Company News

  • Nanox Announces Distribution Agreement with Medworks for Nanox.AI in Greece

  • Nanox.AI Advances Commercial Collaboration with Dosy Health to Bring AI Cardiac Solution to Thailand

  • Nanox Announces That Board Has Approved Cost Reduction and Operational Efficiency Measures

  • USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows

  • TCT 2026 Clinical Data Reveals 84% Reporting Gap in Aortic Valve Calcification, Highlighting the Potential of Nanox.AI's AVC Solution

  • Nanox Provides Business Update and Furnishes Certain Preliminary Unaudited Financial Data for Third Quarter Ended September 30, 2026

  • Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l.

  • Nanox Selected as One of TIME's Best Inventions of 2026 for its Nanox.ARC X

  • Nano-X Imaging Ltd. (NASDAQ:NNOX) Given Average Recommendation of “Moderate Buy” by Analysts

  • Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica

  • Nano-X Imaging Ltd. (NNOX) Q2 2026 Earnings Call Transcript

  • Nano-X Imaging Q2 Earnings Call Highlights

  • Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates

  • Nanox Signs Distribution Agreement with Associated X-Ray Imaging to Expand Nanox.ARC Adoption Across New England

  • Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026

  • Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom

  • Pomerantz Law Firm Announces the Filing of a Class Action Against Nano-X Imaging Ltd.and Certain Officers – NNOX

  • Bronstein, Gewirtz & Grossman LLC Urges Nano-X Imaging Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

  • Portnoy Law Firm Announces Class Action on Behalf of Nano-X Imaging Ltd. Investors

  • NNOX Shareholder Alert: Nano-X Imaging Ltd. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm